CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

DSpace Repository

CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

Author: Steinberg, Gary D.; Shore, Neal D.; Redorta, Joan Palou; Galsky, Matthew D.; Bedke, Jens; Ku, Ja Hyeon; Kretkowski, Michal; Hu, Hailong; Penkov, Konstantin; Vermette, Jennifer J.; Tarazi, Jamal C.; Randall, Alison E.; Pierce, Kristen J.; Saltzstein, Daniel; Powles, Thomas B.
Tübinger Autor(en):
Bedke, Jens
Published in: Future Oncology (2024), Bd. 20, H. 14, S. 891-901
Verlagsangabe: London : Future Medicine Ltd
Language: English
Full text: http://dx.doi.org/10.2217/fon-2023-0271
ISSN: 1479-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)